PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.22%
Revenue growth above 1.5x RUN's 12.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
64.11%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
165.49%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
49.95%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
245.39%
Net income growth at 50-75% of RUN's 460.66%. Martin Whitman would question fundamental disadvantages in expenses or demand.
325.00%
EPS growth at 50-75% of RUN's 456.14%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
316.67%
Diluted EPS growth at 50-75% of RUN's 436.85%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
8.51%
Share count expansion well above RUN's 1.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
17.51%
Diluted share count expanding well above RUN's 1.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
105.32%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
53.59%
FCF growth under 50% of RUN's 156.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
251.78%
Similar 10Y revenue/share CAGR to RUN's 231.43%. Walter Schloss might see both firms benefiting from the same long-term demand.
251.78%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
283.50%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-97.12%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-97.12%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-56.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
143.82%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
143.82%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
87.49%
Below 50% of RUN's 220.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.40%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
96.93%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
-23.39%
Inventory is declining while RUN stands at 18.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
16.24%
Asset growth above 1.5x RUN's 4.18%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.98%
50-75% of RUN's 11.80%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
43.10%
Debt growth far above RUN's 3.38%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-13.03%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.79%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.